Medicare Enrolled

Dr. Thomas O'Laughlin, MD

Pain Medicine (Physical Medicine & Rehabilitation) Physician · Clovis, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
255 W BULLARD AVE STE 112, Clovis, CA 93612
5594980268
In practice since 2006 (19 years)
NPI: 1306886916 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. O'Laughlin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. O'Laughlin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. O'Laughlin

Dr. Thomas O'Laughlin is a pain medicine physician in Clovis, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. O'Laughlin performed 1,601 Medicare services across 652 unique beneficiaries.

Between the years covered by Open Payments, Dr. O'Laughlin received a total of $49,648 from 49 pharmaceutical and/or device companies across 712 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine (physical medicine & rehabilitation) physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. O'Laughlin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 50% volume in CA $49,648 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,601
Medicare services
Top 50% in CA for pain medicine (physical medicine & rehabilitation) physician
652
Unique beneficiaries
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~84 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
412 $59 $150
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
305 $0 $10
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
227 $137 $500
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
162 $88 $200
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
109 $101 $450
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
108 $67 $400
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
74 $26 $125
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
66 $136 $500
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
35 $39 $102
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
29 $12 $100
Hospital discharge day management, 30 minutes or less
This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less.
21 $62 $175
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
19 $8 $50
Trigger point injection, 3 or more muscles
Injection of medication into three or more specific muscle trigger points to relieve pain.
18 $50 $300
New patient office visit, complex (60-74 min) 16 $163 $900
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$49,648
Total received (2018-2024)
Avg $7,093/year across 7 years
Top 5% in CA for pain medicine (physical medicine & rehabilitation) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
712
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$38,108 (76.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,851 (21.9%)
Other
Charitable contributions, space rental, and other categories
$689 (1.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,364
2023
$1,456
2022
$1,956
2021
$1,913
2020
$2,443
2019
$7,854
2018
$31,663

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Cadwell Industries, INC
$689
Collegium Pharmaceutical, Inc.
$525
Indivior Inc.
$202
Phathom Pharmaceuticals, Inc.
$153
Medtronic, Inc.
$148
PFIZER INC.
$118
Saluda Medical Americas, Inc.
$101
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$101
ABBVIE INC.
$83
BIOTRONIK NRO, Inc.
$70
Lundbeck LLC
$31
Takeda Pharmaceuticals U.S.A., Inc.
$31
Boston Scientific Corporation
$28
Otsuka America Pharmaceutical, Inc.
$26
Axsome Therapeutics, Inc.
$21
Illumina, Inc.
$20
Virtus Pharmaceuticals LLC
$19
Top 3 companies account for 59.9% of 2024 payments
All-time payments by company (2018-2024) ›
BioDelivery Sciences International, Inc.
$36,893
Collegium Pharmaceutical, Inc.
$1,505
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$1,341
ABBVIE INC.
$782
Cadwell Industries, INC
$689
Otsuka America Pharmaceutical, Inc.
$657
AbbVie Inc.
$653
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$645
Indivior Inc.
$535
USWM, LLC
$408
Takeda Pharmaceuticals U.S.A., Inc.
$399
PFIZER INC.
$393
Allergan, Inc.
$388
Medtronic, Inc.
$376
Biohaven Pharmaceuticals, Inc.
$347
Biohaven Pharmaceutical Holding Company Ltd.
$324
Amgen Inc.
$324
Pernix Therapeutics Holdings, Inc.
$301
Teva Pharmaceuticals USA, Inc.
$291
Avanir Pharmaceuticals, Inc.
$236
Supernus Pharmaceuticals, Inc.
$224
Boston Scientific Corporation
$184
Vision Quest Industries Inc.
$162
Phathom Pharmaceuticals, Inc.
$153
ARBOR PHARMACEUTICALS, INC.
$153
AstraZeneca Pharmaceuticals LP
$149
Novartis Pharmaceuticals Corporation
$136
Saluda Medical Americas, Inc.
$101
BOSTON SCIENTIFIC CORPORATION
$85
Lilly USA, LLC
$78
Sentynl Therapeutics, Inc.
$76
BIOTRONIK NRO, Inc.
$70
IDORSIA PHARMACEUTICALS US INC
$60
Lundbeck LLC
$60
Arbor Pharmaceuticals, Inc.
$54
Axsome Therapeutics, Inc.
$49
Upsher-Smith Laboratories LLC
$44
Virtus Pharmaceuticals LLC
$42
Horizon Therapeutics plc
$36
Shionogi Inc
$36
UPSHER-SMITH LABORATORIES LLC
$34
Forte Bio-Pharma LLC
$29
Daiichi Sankyo Inc.
$27
Assertio Therapeutics, Inc.
$25
GRT US Holding, Inc.
$24
Kowa Pharmaceuticals America, Inc.
$20
Illumina, Inc.
$20
Vertiflex, Inc.
$16
Merck Sharp & Dohme Corporation
$13
Top 3 companies account for 80.0% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · ANDEXXA · Aimovig · Amitiza · Auvelity · BELBUCA · BELSOMRA · BUNAVAIL · BUNAVAIL 2.1 mg 30-count box · Belbuca · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · EMBEDA · EMGALITY · Edarbi · Evoke · Horizant · INTELLIS ADAPTIVESTIM · LEVORPHANOL TARTRATE · LINEAR · LUCEMYRA · LYRICA · Levorphanol · Lucemyra · MOTEGRITY · MOVANTIK · Motegrity · Movantik · NALOCET · NUEDEXTA · NURTEC ODT · Nucynta · ONZETRA Xsail · OXTELLAR XR · Oncology Testing · PAXLOVID · PENNSAID · Prospera · QULIPTA · QUVIVIQ · Qutenza · RELISTOR · RELISTOR ORAL · REXULTI · REYVOW · SAMSCA · SILENOR · SPECTRA WAVEWRITER · SUBLOCADE · SYNCHROMEDII · Seglentis · Spectra WaveWriter · Superion ISS · Symproic · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TROKENDI XR · Trintellix · UBRELVY · VOQUEZNA · XTAMPZA · XTAMPZAER · ZIMHI · ZIPSOR · ZOHYDRO ER · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (77%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pain medicine (physical medicine & rehabilitation) physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for pain medicine (physical medicine & rehabilitation) physician in CA.

Looking for a pain medicine physician in Clovis?
Compare pain medicine physicians in the Clovis area by procedure volume, costs, and industry payment transparency.
Browse pain medicine physicians nearby

Geographic Context

Pain medicine physicians within 10 mi
4
Per 100K population
0.4
County median income
$71,434
Nearest hospital
CLOVIS COMMUNITY MEDICAL CENTER
1.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. O'Laughlin is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 5% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. O'Laughlin experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. O'Laughlin performed 412 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. O'Laughlin receive payments from pharmaceutical companies?
Yes. Dr. O'Laughlin received a total of $49,648 from 49 companies across 712 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. O'Laughlin's costs compare to other pain medicine physicians in Clovis?
Dr. O'Laughlin's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. O'Laughlin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →